Päivi Pihlajamaa and Alessio Nahmad & Ella Goldschmidt

Date and Time

March 6, 2023
01:00PM - 02:00PM EST

pihlajamaa_paivi-336x280_01.jpeg
Päivi Pihlajamaa (Taipale Lab). University of Helsinki, University of Cambridge 

A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites

Nature Biotechnology 2022

 

alessio_and_ella
Alessio Nahmad (Barzel Lab) & Ella Goldschmidt (Madi Lab). Tel Aviv University

Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage

Nature Biotechnology 2022

Recording: https://harvard.zoom.us/rec/share/cfseaULX7Kcy1TSdMQH2fpGJ2q7Ehx-Gmu7l939P7Hx1lJT0dP20H8bpfyEjy7UH.vu6QIUBxiVxBSmtl 
 

Share on:
Save: Add to calendar